The effect of a number of rifamycin det-atives and related compounds on the reversibility of the rifampin-induced virus maturation block was studied by using BHK-21 cells infected with vaccinia virus. All of the derivatives of 3-formyl rifamycin SV maintained this block, the required concentration varying from 100 to 1,000 ug ml. These compounds vary only in the nature of the side-chain attached to the 3C atom on the naphthohydroquinone moiety; no obvious correlation between the nature of this side-chain and antiviral activity was found. Streptovaricin complex and tolypomycin R also maintained the maturation block; tolypomycin also produced marked alterations in the appearance of the viroplasm contained in rifampininduced inclusions and immature virus particles.
Rifampin, a semisynthetic antibiotic of the ansamycin group, specifically inhibits the growth of vaccinia virus, preventing the formation of immature virus particles (6, 11, 13, 19) . This block is rapidly reversed after removal of the drug in the presence of inhibitors of protein, deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) synthesis (10) (11) (12) (13) , strongly suggesting that rifampin does not inhibit the synthesis of immature particle components but that it inhibits their assembly. Rifampin is known to bind firmly and specifically to bacterial DNA-dependent RNA polymerase, with subsequent inhibition of transcription (3, 18, 22) , but extensive studies with vaccinia virus have failed to demonstrate a similar interaction, the activity of the virion DNA-dependent RNA polymerase and the synthesis in infected cells of viral DNA, RNA, and early and late proteins not being prevented by concentrations of rifampin sufficient to inhibit virus growth completely (1, 2, 8, 10, 19) .
Rifampin is synthesized by the condensation of 3-formyl rifamycin SV with 1-amino 4-methyl piperazine (9) . Studies with these compounds have shown that the antiviral activity of rifampin resides in the rifamycin moiety of the compound (Follett and Pennington, in press). In this paper we report the results of studies on the antiviral activity of several semisynthetic rifamycin derivatives (9, 16) and two naturally occurring ansamycin antibiotics, streptovaricin (15) and tolypomycin-R- (7) .
MATERIALS AND METHODS
Cell cultures. BHK-21 cells (clone 13) were grown as monolayers in 5-cm plastic petri dishes or 20-oz (ca. 600 ml) glass bottles in Eagles medium containing 10%70 (v/v) calf serum and 10% Tryptose phosphate broth.
Virus production and assay. Vaccinia virus (Evans vaccine strain) was grown in monolayers of BHK cells. Estimates of infectivity were made by plaque assay by using cell monolayers with a liquid overlay. Two days after infection, the monolayers were stained with Giemsa stain and the plaques were counted.
Ansamycin antibiotics and other inhibitors. Rifampin and rifamycin derivatives were supplied by G. Lancini, Lepetit Spa, Milan, Italy. Tolypomycin R was obtained from T. Kishi, Takeda Chemical Industries Ltd., Osaka, Japan, and supplies of streptovaricin were furnished by Calbiochem Ltd., London, and by Akio Nagata of the Toyo Jozo Co. Ltd., Tagata-Gun Shizuoka-Ken, Japan. Streptovaricin was supplied as a complex and was used without any attempt to separate the various components. Formulas, chemical nomenclature, and abbreviations of the rifamycin derivatives are shown in Fig. 1 39 , and the streptovaricin complex at concentrations up to 100 ,g/ml. AF/ABDP and tolypomycin R were tested at a concentration of 10 ,ug/ml; again no significant inhibition was detected.
Plaque formation, however, was abolished by 3-formyl rifamycin SV and compound 18 at concentrations above 40 lAg/ml (Table 1) . The specificity of this effect was tested by examining the effect of these compounds on the plaque-forming ability of a rifampin-resistant variant of vaccinia (20) . As with wild-type virus, 50 ,ug of the compounds per mnl prevented plaque formation by the variant (Table 1) .
Rifampin-induced maturation block and its reversal. As we wished to compare the antiviral activity of the test compounds with that of rifampin, the effect of these antibiotics on the reversibility of the rifampin-induced maturation block was examined by electron microscopy. This approach was chosen because it required only short periods of exposure of infected cells to test antibiotics, thus allowing the examination of toxic compounds, and because it allowed the detection of immature virus particles which cannot be unequivocally detected by any other procedure. It has been shown that the development of these particles after the removal of rifampin is not affected by inhibitors of DNA, RNA, and protein synthesis, (10) (11) (12) (13) 17 hr at 37 C. The medium was then poured off and immediately replaced with warm medium lacking rifampin. Samples were prepared for electron microscopy after fixation in situ with glutaraldehyde at room temperature for 15 min.
After incubation for 1 min in normal medium, no evidence of any development of immature virus particles was detected either at the periphery of the RI inclusions or in the surrounding cyto--plasm. In samples incubated for 2 min, typical curved immature particle membranes with associated spicules were seen at the periphery of the inclusions and in the surrounding cytoplasm (Fig. 5) . Occasional short regions of markedly increased density were also observed at the periphery of some inclusions (Fig. 5) ; no curvature was apparent in these regions. Tubular structures were still present in some inclusions. Continued incubation for 5 All of the derivatives of 3-formyl rifamycin SV were capable of maintaining the rifampicininduced maturation block (Table 2) . Wide variations in the concentration required to maintain a complete block were found. Rifamycin SV and AF/ABDP were less effective than any of the other derivatives, producing only partial maintenance of the maturation block even at a concentration of 1,000 ,ug/ml.
Tolypomycin R and streptovaricin also proved capable of maintaining the maturation block produced by rifampin although high concentrations were required. In addition, tolypomycin R produced a marked increase in the granularity of the RI inclusions (Fig. 6 ). This granularity was not apparent in control samples which had been maintained in rifampin throughout and which had been fixed and processed together with the sample incubated in tolypomycin. Reversibility of maturation block maintained by antibiotics other than rifampin. The reversibility of the maturation block maintained by 3-formyl rifamycin SV and tolypomycin R was examined as follows. After substitution of the test compound for rifampin and subsequent incubation, the inhibitor under test was removed and fresh medium lacking inhibitor was added. Incubation was continued for 1 hr, and the cells were then fixed and examined. In experiments with both compounds, the rifampin-induced maturation block maintained by them was released after their removal, immature particles developing at the periphery of the RI inclusions and in the cytoplasmic matrix. The granular appearance of the viroplasm produced by tolypomycin R persisted after removal of the drug, and complete immature particles contained material with a similar degree of granularity to that seen in the RI inclusions. Immature particles containing granular material were also observed in cells treated with concentrations of tolypomycin R which only partially inhibited virus maturation (Fig. 7 ).
DISCUSSION
The experiments described here indicate that the block in vaccinia virus maturation induced by rifampin can be maintained by other ansamycin antibiotics. These observations contrast sharply with the failure of inhibitors of protein, RNA and DNA synthesis, and other general metabolic inhibitors to affect the development of immature particles from RI inclusions after the removal of rifampin. We suggest that the maintenance of the virus maturation block by the ansamycin antibiotics we have tested indicates that these compounds exert a specific antiviral effect with the same molecular mechanism as that of rifampin. The reversibility of the maturation block maintained by 3-formyl rifamycin SV that these variations in antiviral activity reflect either differences in the ability of the compounds to enter the cells or to reach critical concentration at some specific location in the cell or differences in the interaction of the compounds with a viral component. However, it is clear that the specific antiviral activity of all these compounds resides in the rifamycin moiety. This conclusion differs from that of Thiry and Lancini (21) who reported that the antiviral activity of rifampin resides in the amino-methyl-piperazine side-chain of the molecule. Their studies, however, did not clearly show that the antiviral effect they observed was specific and unrelated to cytotoxic effects. We have already shown that in our system high concentrations of 1-amino 4-methyl piperazine display no specific antiviral activity [Follett and Pennington, Nature (London), in press].
It is clear that the inhibition of virus plaque formation by relatively low concentrations of 3- formyl rifamycin SV and compound 18 is not due solely to a rifampin-like effect, as both of these compounds inhibit plaque formation by rifampinresistant vaccinia virus. Supporting this view is the observation that low concentrations of 3- formyl rifamycin SV and compound 18 have little inhibitory effect on virus maturation when substituted for rifampin late in infection, both compounds exerting a rifampin-like effect on virus maturation only at concentrations of 200 ,g/ml and 100 ,ug/ml, respectively. Two possibilities which may explain these findings and which are under investigation are that 3-formyl rifamycin SV and compound 18 may exert a specific antiviral effect at a stage in virus development earlier than that of rifampin, possibly on the virus DNAdependent RNA polymerase (see below), or alternatively that the inhibition of virus plaque formation follows the toxic effects of the compounds on BHK cells.
The streptovaricin complex tested in this study showed antiviral activity only at very high concentrations. It is possible that only a minor component of the complex possesses antiviral activity, a situation which would be similar to that found with cowpoxvirus, which, however, is inhibited by much smaller amounts of complex (14) . Both streptovaricin and tolypomycin differ structurally from rifamycin SV in both the aliphatic chain and the chromophoric moiety. Tolypomycin R does not possess a side-chain attached to the 3-C position of the chromophore, It has been shown recently that the compounds examined in this study exert an inhibitory effect on the virion-associated DNA-dependent RNA polymerase of vaccinia virus (Szilagyi and Pennington, submitted for publication). The results of this study showed that 3-formyl rifamycin SV and AF/ABDP at concentrations of 150 ,ug/ml and 100 ,g/ml, respectively, produced a profound inhibition of enzymatic activity, this concentration of compound 18 inhibiting the enzyme partially. Raising the concentration of compound 18 to 500 ,ug/ml produced a complete inhibition of activity; a partial inhibitory effect was produced by this concentration of compound 39, tolypomycin R, and rifampin. There is no correlation between the concentration of antibiotic required to maintain the maturation block and that required to inhibit enzyme activity. Rifampin, tolypomycin R, and compound 18, for example, completely block virus maturation at concentrations less than those which produce a partial inhibition of enzyme activity, and, conversely, AF/ABDP produces a profound inhibition of enzyme activity at concentrations much lower than those required to block viral maturation. A further distinction between the ability of compounds to inhibit viral maturation and their ability to inhibit the virion RNA polymerase was indicated by the finding that the virion polymerase of mutants able to grow in the presence of 100 jg of rifampin per ml was inhibited by the compounds to the same degree as that of wild-type virus.
The observation that incubation of cells with many of the ansamycin antibiotics led to gross change in mitochondrial structure is of considerable interest in view of recent reports suggesting that rifamycins may inhibit eucaryote mitochondrial RNA synthesis (4, 17) . Possible relationships between the cytotoxicity of these compounds and their effects on mitochondria are being further investigated.
